Rudolph E Willis, M.D.
CEO / Cofounder
BA: Northwestern University
Chemistry / Biology (honors)
MD: Washington University School of Medicine,
Post Doc: NIH, National Cancer Institute -
Laboratory of Tumor Cell Biology
Prior: Director of Clinical Trials subunit -
Washington University School of
Medicine, St. Louis
Faculty:Clinical Assistant Professor of Medicine
Drexel University College of Medicine
Scott M Kahn, Ph.D.
CSO / Cofounder
BA: Brandeis University
Chemistry (honors), Biochemistry
Ph.D.: SUNY @ Stony Brook
Biochemistry and Molecular Biology
Chairman, Biomarkers Council, International
Cancer Advocacy Network
Prior: Member, Columbia Herbert Irving
Comprehensive Cancer Center
Faculty Member, Dept. of Radiation Oncology;
Urology, Columbia University
Director of Basic Urologic Research, St. Luke's -
Roosevelt Hospital Center
Charles Karan Ph.D.,
High Throughput Screening Center
JP Sultzburger Columbia Genome Center
Dr. Karan provides expertise in assay
development and execution, using state of the art screening tools. He is an expert in small molecule chemistry.
Dr. Joseph Mo
CEO NAL Pharmaceuticals (private)
Founder of Nexmed, Inc. (Nasdaq NEXM)
NAL develops proprietary and improved drug delivery systems that exhibit enhanced patient compliance, safety, and/or efficacy.
Shi-Xian Deng, Ph.D.
Chemistry Group Coordinator
Organic Chemistry Collaborative Center (OCCC) Columbia Irving Inst. for Clinical and Translational Research
OCCC specializes in organic synthesis, drug discovery, and pharmacokinetic studies.
Since 2003, 7 patents have been licensed.
Marcia K. Horn, President / CEO
International Cancer Advocacy Network (ICAN)
International Cancer Advocacy Network is a 501(c)(3) tax-exempt charitable organization providing direct patient navigation for Stage IV cancer cases throughout the United States and in 53 countries. ICAN has assisted over 8,000 patients on an individual basis since its founding in 1996, and is highly experienced with patient needs, including molecular profiling and clinical trial placement.